Therapeutic compositions for treatment of human immunodeficiency virus
The present application relates to therapeutic compositions for the treatment of human immunodeficiency virus infection. The present application provides a solid oral dosage form comprising a compound of formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutic...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
26.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present application relates to therapeutic compositions for the treatment of human immunodeficiency virus infection. The present application provides a solid oral dosage form comprising a compound of formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
本申请涉及用于治疗人免疫缺陷病毒感染的治疗组合物。具体地,本申请提供了一种固体口服剂型,其包含式I化合物或其药学上可接受的盐、替诺福韦艾拉酚胺或其药学上可接受的盐以及恩曲他滨或其药学上可接受的盐。 |
---|---|
Bibliography: | Application Number: CN202110669391 |